Edition:
United Kingdom

Imv Inc (IMV.TO)

IMV.TO on Toronto Stock Exchange

3.95CAD
19 Aug 2019
Change (% chg)

$-0.12 (-2.95%)
Prev Close
$4.07
Open
$4.00
Day's High
$4.00
Day's Low
$3.86
Volume
13,684
Avg. Vol
52,881
52-wk High
$8.49
52-wk Low
$3.06

About

Imv Inc, formerly known as Immunovaccine Inc is a Canada-based clinical-stage immuno oncology company. The Company develops products based on its vaccine enhancement platform with a primary focus on T lymphocytes (T cell) activating therapies for cancer. The Company's DepoVax adjuvanting/delivery platform produces immune... (more)

Overall

Beta: 1.41
Market Cap(Mil.): $189.29
Shares Outstanding(Mil.): 50.61
Dividend: --
Yield (%): --

Financials

  IMV.TO Industry Sector
P/E (TTM): -- 98.31 33.85
EPS (TTM): -0.54 -- --
ROI: -80.70 7.52 12.69
ROE: -116.83 7.94 17.13
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates